Regulation 2019/6 on veterinary medicinal products lays down the setting up of a pharmacovigilance database linked with the product database.

They both shall be developed and maintained by the European Medicines Agency (EMA) in collaboration with the Member States. FVE has provided its inputs highlighting that enough resources shall be put in place and both databases are useful for their most important end users, namely veterinarians. FVE also calls for sufficient and proper stakeholders involvement.